Healthcare -
Biotechnology - NASDAQ - US
$ 1.205
2.12 %
$ 94.7 M
Market Cap
-1.8
P/E
SLS - OTHER CURRENT ASSETS
Other Current Assets SLS - SELLAS Life Sciences Group, Inc.
642 K
LAST VALUE
-38.35%
2 YEAR CAGR
5.08%
5 YEAR CAGR
-8.72%
10 YEAR CAGR